Erlotinib Tablets are a medicine used in the treatment of certain types of cancer, specifically targeting abnormal cell growth. They belong to a class of drugs called tyrosine kinase inhibitors (TKIs).

Here are the key details:

• Composition: Each tablet contains Erlotinib hydrochloride as the active ingredient, commonly in strengths like 25 mg, 100 mg, and 150 mg.

• Dosage Form: Oral tablets, usually taken once daily, on an empty stomach or as directed by a doctor.

• Mode of Action:

  • Erlotinib inhibits the epidermal growth factor receptor (EGFR) tyrosine kinase, which is involved in the growth and spread of cancer cells.

  • By blocking EGFR, it slows cancer cell growth and can induce cancer cell death.

• Uses:

  • Non-small cell lung cancer (NSCLC) – particularly in patients with EGFR mutations.

  • Pancreatic cancer – in combination with other chemotherapeutic agents.

• Treatment Goal: To slow cancer progression, reduce tumor size, and improve survival in patients with EGFR-positive cancers.

• Side Effects:

  • Common: rash, diarrhea, loss of appetite, fatigue, nausea, vomiting.

  • Less common/serious: liver problems, interstitial lung disease, severe skin reactions, eye irritation.

• Precautions:

  • Regular monitoring of liver function and skin condition is recommended.

  • Avoid taking with strong acid-reducing medications unless advised by a doctor, as they may reduce absorption.

  • Not recommended during pregnancy or breastfeeding.

  • Can interact with certain medications that affect liver enzymes, altering drug levels.

👉 Erlotinib is a targeted cancer therapy, specifically effective for cancers driven by EGFR mutations, providing a more precise approach than traditional chemotherapy.